Department of Pharmacology, School of Pharmacy, University of Granada, Centro de Investigaciones Biomédicas, Granada, Spain.
Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.
Acta Physiol (Oxf). 2019 Sep;227(1):e13285. doi: 10.1111/apha.13285. Epub 2019 Jun 2.
High blood pressure (BP) is associated with gut microbiota dysbiosis. The aim of this study was to investigate whether changes in gut microbiota induced by exchanging the gut microbiota between spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) alter the gut-immune system interaction inducing changes in vascular function and BP.
Twenty-week-old recipient WKY and SHR were orally gavaged with donor faecal contents from WKY or SHR. In additional experiments, we used a design to determine whether blockade of B7-dependent costimulation with CTLA4-Ig or blockade of IL-17 with IL-17-neutralizing antibody could prevent hypertension caused by faecal microbiota transplantation (FMT) from SHR to WKY.
Correlation analyses identified the bacterial abundance of Turicibacter and S24-7_g that, respectively, positively and negatively correlated with systolic BP. FMT from WKY rats to SHR rats reduced basal systolic BP, restored the imbalance between Th17/Treg in mesenteric lymph nodes (MLNs) and aorta, and improved endothelial dysfunction and vascular oxidative status found in SHR transplanted with SHR faeces. FMT from SHR to WKY increased CD80 and CD86 mRNA levels and T cells activation in MLNs, circulating T cells, aortic T cell infiltration, impaired endothelial function and increased basal SBP. These effects were abolished by blockade of B7-dependent costimulation with CTLA4-Ig. IL-17a neutralizing antibody reduced SBP and improved endothelial dysfunction induced by FMT from SHR to WKY.
Gut microbiota is an important factor involved in the control of BP, as a consequence of its effect in T-cell activation in gut immune system and vascular T-cells accumulation.
高血压(BP)与肠道微生物失调有关。本研究旨在探讨自发性高血压大鼠(SHR)和正常血压 Wistar-Kyoto(WKY)之间肠道微生物群的变化是否通过交换肠道微生物群而改变肠道-免疫系统相互作用,从而导致血管功能和血压的变化。
20 周龄的受体 WKY 和 SHR 经口给予 WKY 或 SHR 的供体粪便内容物。在额外的实验中,我们使用一种设计来确定 CTLA4-Ig 阻断 B7 依赖性共刺激或 IL-17 中和抗体阻断 IL-17 是否可以防止 SHR 粪便微生物群移植(FMT)引起的 WKY 高血压。
相关分析确定了 Turicibacter 和 S24-7_g 的细菌丰度,它们分别与收缩压呈正相关和负相关。WKY 大鼠到 SHR 大鼠的 FMT 降低了基础收缩压,恢复了肠系膜淋巴结(MLNs)和主动脉中 Th17/Treg 的失衡,并改善了 SHR 接受 SHR 粪便移植时发现的内皮功能障碍和血管氧化状态。SHR 到 WKY 的 FMT 增加了 MLNs 中 CD80 和 CD86 mRNA 水平和 T 细胞活化、循环 T 细胞、主动脉 T 细胞浸润、内皮功能受损和基础 SBP 升高。这些作用被 CTLA4-Ig 阻断 B7 依赖性共刺激所消除。IL-17a 中和抗体降低了 SHR 到 WKY 的 FMT 引起的 SBP 和改善了内皮功能障碍。
肠道微生物群是控制血压的一个重要因素,因为它会影响肠道免疫系统中的 T 细胞活化和血管 T 细胞积聚。